Evivo Corporate News

UC Davis Scientific Team Strengthens Case for Bifidobacterium in the Fight Against Antibiotic Resistance

UC Davis Scientific Team Strengthens Case for Bifidobacterium in the Fight Against Antibiotic Resistance

A new study published in mSphere found that children with higher levels of the beneficial bacteria, Bifidobacterium, in their gut microbiome had reduced abundance and lower frequency

Dr. Bethany Henrick

Evivo Bifidobacteria Screening Test

Evivo scientists have developed a prototype of the first and only point-of-care screening test designed to identify infants that do not have enough Bifidobacterium to create a stable infant gut microbiome.

Evivo Supports a Protective Environment in the Infant Gut

Evivo Supports a Protective Environment in the Infant Gut

Our gastrointestinal tract helps protect our bodies from harmful bacteria, and the protective barrier that lines the walls of the large intestine plays a lead role.

Virulence

Significant Reduction in Pathogenic Gut Bacteria Lowers Potential for Infection Risk in Infants Fed B. infantis EVC001

The mix of good and bad bacteria that live in our gut, and the amount of each, makes a big difference in our baby’s health.

Evolve-BioSystems-Series-C-Financing

Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo®

Evolve BioSystems, Inc., the leading infant gut microbiome company, today announced that it has comp

Landmark Study to Address Global Malnutrition and Restorative Effect of Infant Probiotic

Landmark Study to Address Global Malnutrition and Restorative Effect of Infant Probiotic

Evivo is on a mission to help improve gut health for babies all over the world.

Fecal pH

New Study Shows Significant Changes to Infant Fecal pH Over Last 100 Years

Evolve BioSystems today announced new research that connects elevated infant fecal pH levels to a profound change in the infant gut microbiome, including the disappearance of a beneficial bacterium that may be

Evolve BioSystems’ Activated B. infantis EVC001 Demonstrates Substantial and Persistent Remodeling of the Infant Gut Microbiome

Evolve BioSystems’ Activated Bifidobacteria infantis EVC001 Demonstrates Substantial and Persistent Remodeling of the Infant Gut Microbiome

Evolve BioSystems today announced positive results from their landmark clinical trial in support of Evivo, an activated form of the beneficial bact

Probiotics and breastfeeding reduces potential antibiotic resistance

Probiotics and breastfeeding reduces potential antibiotic resistance in children

Targeted probiotic supplementation in breastfed infants can significantly reduce the potential for antibiotic resistance, new research presented at the 51st ESPGHAN Annual Meeting.

Evivo - Health Canada Approval

Evivo Gains Health Canada Approval, Providing First International Expansion Opportunity

DAVIS, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Evolve BioSystems, Inc., a microbiome company developing novel solutions to resolve infant gut dysbiosis, is pleased to announce that Evivo™ (activated B. infantis EVC001, ActiBif®) has now been granted regulatory approval for sale in Canada.

Evivo-Survey-Identifies-Moms-Misperceptions-About-Breast-Milk-and-Baby-Gut-Microbiome

Evivo Survey Identifies Moms' Misperceptions About Breast Milk and Baby Gut Microbiome

U.S. Moms Know There's a Connection Between Breast Milk and the Infant Gut, But Most Don't Know Up To 15% of Breast Milk Nutrients Are Wasted Yet Critical During First Six Months.

Evivo Protects Babies From the Inside Out

Evivo Protects Babies From the Inside Out

Evolve BioSystems, Inc. announces the introduction of Evivo, the first and only probiotic clinically proven to restore a baby's gut microbiome to its original, natural state. Once daily Evivo helps develop a healthy immune system and metabolism to set up babies for healthier lives.